NEW YORK, Nov. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Life Science Analytics', Metabolic Endocrinology Hypocalcemia contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of endocrinology drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Life Science Analytics' Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
% of Products by Phase of Development
No. of Products by Phase of Development
Marketed Products vs. Pipeline Products
Company Overview - Pipeline Projects
--Top 5 Companies in Marketed Hypocalcemia Products
Full Pipeline View
--Product Details : Approved
--Product Details : On the Market
To order this report: Metabolic Endocrinology Hypocalcemia
Nicolas Bombourg Reportlinker Email: email@example.com US: (805)652-2626 Intl: +1 805-652-2626
Copyright©2009 PR Newswire.
All rights reserved